Nazia J. Khan is an associate in the Corporate Practice Group in the firm’s New York office. Ms. Khan’s practice focuses on corporate finance and securities laws. She represents companies and underwriters in public and private corporate finance transactions including initial public offerings, shelf registrations, registered direct transactions, PIPEs, private placements and other securities offerings.
In addition, Ms. Khan represents publicly-held companies with their reporting obligations under the Exchange Act and with NASDAQ, NYSE and other exchange listing and compliance matters including matters involving FINRA.
J.D., California Western School of Law, 2013, with honors
B.S., George Mason University, 2010, cum laude
Represented Immuron Limited in its $6.1 million public offering and uplisting to Nasdaq
Represented Aridis Pharmaceuticals, Inc. in its $26 million public offering and uplisting to Nasdaq